Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06386185 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography

Study acronym: DRAPE
StatusRecruiting
PhaseNot specified
Started2024-09-06
View on ClinicalTrials.gov ↗

Amendment history

2025-06-17
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-04-01→confirmed 2024-09-06
Study sitesdetails revised at 5 of 5 sites
2025-01-16
Study Status, Contacts/Locations v3
Start date2024-12-01→2025-04-01
Study sitescontacts updated at 5 of 5 sites
2024-11-19
Study Status, Oversight v2
Re-verified, no change to tracked fields
2024-11-05
Study Status, Outcome Measures, Contacts/Locations v1
Primary completion date2026-07-01→2026-12-01
Completion date2026-11-01→2026-12-01
Start date2024-07-01→2024-12-01
Secondary endpoints2 entries, revised
Assess the impact of additional ECGelectrocardiogram markers on existing PHpulmonary hypertension probability stratification
2024-04-23
Original filing
The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension. The main questions it aims to answer are: Can novel markers in ECG and echocardiography suggest the presence of PH? Can existing screening guidelines be improved with the addition of these markers?
Trial Details
NCT Number NCT06386185
Lead Sponsor Royal United Hospitals Bath NHS Foundation Trust
Collaborators: Sheffield Teaching Hospitals NHS Foundation Trust, Royal Free Hospital NHS Foundation Trust, Golden Jubilee National Hospital, Papworth Hospital NHS Foundation Trust, University of Bath
Conditions Pulmonary Hypertension
Enrollment 2,500 participants
Start Date 2024-09-06
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-18